Clinical Trial Update: CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial is evaluating CMV-specific HIV-CAR T cells as an immunotherapy for HIV/AIDS; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• CMV-specific HIV-CAR T Cells

Snippet

Sponsor: City of Hope Medical Center | Conditions: HIV-1 | EARLY_Phase 1 | Status: RECRUITING